A novel model for Ki67 assessment in breast cancer.

Quinci Romero; Pär-Ola Bendahl; Mårten Fernö; Dorthe Grabau; Signe Borgquist

doi:10.1186/1746-1596-9-118

A novel model for Ki67 assessment in breast cancer.

Quinci Romero, Pär-Ola Bendahl, Mårten Fernö, Dorthe Grabau, Signe Borgquist

Research output: Contribution to journal › Article › peer-review

32 Citations (SciVal)

170 Downloads (Pure)

Abstract

Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.

Original language	English
Article number	118
Journal	Diagnostic Pathology
Volume	9
Issue number	1
DOIs	https://doi.org/10.1186/1746-1596-9-118
Publication status	Published - 2014

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pathology, (Lund) (013030000), Oncology, MV (013035000)

Subject classification (UKÄ)

Cancer and Oncology

Access to Document

10.1186/1746-1596-9-118Licence: CC BY

BMC__Romero_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24934660?dopt=Abstract

Cite this

@article{54ac8b7c69bf434e9ec1063165e6c628,

title = "A novel model for Ki67 assessment in breast cancer.",

abstract = "Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.",

author = "Quinci Romero and P{\"a}r-Ola Bendahl and M{\aa}rten Fern{\"o} and Dorthe Grabau and Signe Borgquist",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology, (Lund) (013030000), Oncology, MV (013035000)",

year = "2014",

doi = "10.1186/1746-1596-9-118",

language = "English",

volume = "9",

journal = "Diagnostic Pathology",

issn = "1746-1596",

publisher = "BioMed Central (BMC)",

number = "1",

}

TY - JOUR

T1 - A novel model for Ki67 assessment in breast cancer.

AU - Romero, Quinci

AU - Bendahl, Pär-Ola

AU - Fernö, Mårten

AU - Grabau, Dorthe

AU - Borgquist, Signe

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology, (Lund) (013030000), Oncology, MV (013035000)

PY - 2014

Y1 - 2014

N2 - Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.

AB - Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.

U2 - 10.1186/1746-1596-9-118

DO - 10.1186/1746-1596-9-118

M3 - Article

C2 - 24934660

VL - 9

JO - Diagnostic Pathology

JF - Diagnostic Pathology

SN - 1746-1596

IS - 1

M1 - 118

ER -

A novel model for Ki67 assessment in breast cancer.

Abstract

Bibliographical note

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this